1st Quarter - Report — MEDSECUREAN.COM for LUPIN PHARMACEUTICALS (2026)

Firm

MEDSECUREAN.COM

Client

LUPIN PHARMACEUTICALS

Income

$42,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Plicies that promote the long-term sustainability of the U.S. generic pharmaceutical industry and preserve reliable patient access to affordable medicines.

Foreign entity interest: Lupin Pharmaceuticals, Inc. is a U.S. company and a subsidiary of Lupin, Inc., a multinational company.

Lobbyist	Covered position, as disclosed
KATHLEEN JAEGER	—

Contacted: State, Dept of (DOS); SENATE; White House Office; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Tarrifs - generic medicine

Foreign entity interest: Lupin Pharmaceuticals, Inc. is a U.S. company, and a subsidiary Lupin Inc. - a multinational company.

Lobbyist	Covered position, as disclosed
KATHLEEN JAEGER	—

Contacted: White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.